These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 3794999)
21. Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents. Wiles JA; Hashimoto A; Thanassi JA; Cheng J; Incarvito CD; Deshpande M; Pucci MJ; Bradbury BJ J Med Chem; 2006 Jan; 49(1):39-42. PubMed ID: 16392790 [TBL] [Abstract][Full Text] [Related]
22. [The chemistry of antimicrobially active 1-hydroxy-2-pyridones (author's transl)]. Lohaus G; Dittmar W Arzneimittelforschung; 1981; 31(8A):1311-6. PubMed ID: 7197537 [TBL] [Abstract][Full Text] [Related]
23. Discovery of aryl aminoquinazoline pyridones as potent, selective, and orally efficacious inhibitors of receptor tyrosine kinase c-Kit. Hu E; Tasker A; White RD; Kunz RK; Human J; Chen N; Bürli R; Hungate R; Novak P; Itano A; Zhang X; Yu V; Nguyen Y; Tudor Y; Plant M; Flynn S; Xu Y; Meagher KL; Whittington DA; Ng GY J Med Chem; 2008 Jun; 51(11):3065-8. PubMed ID: 18447379 [TBL] [Abstract][Full Text] [Related]
24. Synthesis of new series of 1-Aryl-1,4-dihydro-4-oxo-6-methyl pyridazine-3-carboxylic acid as potential antibacterial agents. Nagawade RR; Khanna VV; Bhagwat SS; Shinde DB Eur J Med Chem; 2005 Dec; 40(12):1325-30. PubMed ID: 16126308 [TBL] [Abstract][Full Text] [Related]
25. C-Terminal properties are important for ring-fused 2-pyridones that interfere with the chaperone function in uropathogenic E. coli. Aberg V; Hedenström M; Pinkner JS; Hultgren SJ; Almqvist F Org Biomol Chem; 2005 Nov; 3(21):3886-92. PubMed ID: 16240004 [TBL] [Abstract][Full Text] [Related]
27. [Studies on pyridonecarboxylic acids as antibacterial agents. XIV. Synthesis and structure-activity relationships of 7,8-disubstituted-1-cyclopropyl-6-methyl-1,4-dihydro-4-oxo-3-quinoline carboxylic acids]. Wang H; Qi J; Sun L; Yu L; Guo H Yao Xue Xue Bao; 1998 Sep; 33(9):675-81. PubMed ID: 12016871 [TBL] [Abstract][Full Text] [Related]
28. Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus. Takahata S; Iida M; Yoshida T; Kumura K; Kitagawa H; Hoshiko S J Antibiot (Tokyo); 2007 Feb; 60(2):123-8. PubMed ID: 17420562 [TBL] [Abstract][Full Text] [Related]
29. Further exploration of antimicrobial ketodihydronicotinic acid derivatives by multiple parallel syntheses. Laursen JB; Nielsen J; Haack T; Pusuluri S; David S; Balakrishna R; Zeng Y; Ma Z; Doyle TB; Mitscher LA Comb Chem High Throughput Screen; 2006 Nov; 9(9):663-81. PubMed ID: 17100572 [TBL] [Abstract][Full Text] [Related]
31. Synthesis of novel 1-pyrazolylpyridin-2-ones as potential anti-inflammatory and analgesic agents. Ismail MM; Ammar YA; El-Zahaby HS; Eisa SI; El-Sayed Barakat S Arch Pharm (Weinheim); 2007 Sep; 340(9):476-82. PubMed ID: 17647214 [TBL] [Abstract][Full Text] [Related]
32. Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents. Song ZC; Ma GY; Lv PC; Li HQ; Xiao ZP; Zhu HL Eur J Med Chem; 2009 Oct; 44(10):3903-8. PubMed ID: 19423200 [TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and crystal structure of selective 2-pyridone tissue factor VIIa inhibitors. Parlow JJ; Kurumbail RG; Stegeman RA; Stevens AM; Stallings WC; South MS J Med Chem; 2003 Oct; 46(22):4696-701. PubMed ID: 14561089 [TBL] [Abstract][Full Text] [Related]
34. Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives. Fassihi A; Abedi D; Saghaie L; Sabet R; Fazeli H; Bostaki G; Deilami O; Sadinpour H Eur J Med Chem; 2009 May; 44(5):2145-57. PubMed ID: 19056147 [TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationships of bioisosteres of a carboxylic acid in a novel class of bacterial translation inhibitors. Ruble JC; Wakefield BD; Kamilar GM; Marotti KR; Melchior E; Sweeney MT; Zurenko GE; Romero DL Bioorg Med Chem Lett; 2007 Jul; 17(14):4040-3. PubMed ID: 17561394 [TBL] [Abstract][Full Text] [Related]
36. Identification and structure-activity relationships of substituted pyridones as inhibitors of Pim-1 kinase. Cheney IW; Yan S; Appleby T; Walker H; Vo T; Yao N; Hamatake R; Hong Z; Wu JZ Bioorg Med Chem Lett; 2007 Mar; 17(6):1679-83. PubMed ID: 17251021 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials. Yeates CL; Batchelor JF; Capon EC; Cheesman NJ; Fry M; Hudson AT; Pudney M; Trimming H; Woolven J; Bueno JM; Chicharro J; Fernández E; Fiandor JM; Gargallo-Viola D; Gómez de las Heras F; Herreros E; León ML J Med Chem; 2008 May; 51(9):2845-52. PubMed ID: 18396855 [TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of a pyrido[2,3-d]pyrimidin-5-one class of anti-inflammatory FMS inhibitors. Huang H; Hutta DA; Hu H; DesJarlais RL; Schubert C; Petrounia IP; Chaikin MA; Manthey CL; Player MR Bioorg Med Chem Lett; 2008 Apr; 18(7):2355-61. PubMed ID: 18342505 [TBL] [Abstract][Full Text] [Related]
40. Phenylimidazole derivatives of 4-pyridone as dual inhibitors of bacterial enoyl-acyl carrier protein reductases FabI and FabK. Kitagawa H; Ozawa T; Takahata S; Iida M; Saito J; Yamada M J Med Chem; 2007 Sep; 50(19):4710-20. PubMed ID: 17713898 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]